Literature DB >> 30918046

Genotyping of Pneumocystis jirovecii by Use of a New Simplified Nomenclature System Based on the Internal Transcribed Spacer Regions and 5.8S rRNA Gene of the rRNA Operon.

Ting Xue1, Zhuang Ma2, Fan Liu3, Wei-Qin Du4, Li He1, Liang Ma5, Chun-Li An6.   

Abstract

Genotyping based on internal transcribed spacer 1 (ITS1) and ITS2 of the rRNA operon has played an important role in understanding the transmission and epidemiology of Pneumocystis jirovecii, one of the major opportunistic pathogens in individuals with AIDS and other immunocompromised individuals. The widespread use of this typing system has resulted in several problems, including inconsistent genotype nomenclatures, difficult data transferability, and complicated interpretation of the length variation in multiple homopolymeric tracts. The aim of this study was to establish a new, simplified genotype nomenclature system for P. jirovecii based on the ITS1 and ITS2 sequences. We first analyzed the complete ITS1, 5.8S rRNA gene, and ITS2 sequences (termed ITS1-5.8S-ITS2) in 27 recent P. jirovecii isolates from China and identified 18 unique genotypes. Subsequently, we performed a comprehensive classification of more than 400 ITS1- and ITS2-related sequences from GenBank and an in-depth evaluation of the length variation of multiple homopolymeric tracts within ITS1-5.8S-ITS2. Integration of the results from these analyses led to a new, simplified genotype nomenclature system including 62 unique ITS1-5.8S-ITS2 genotypes, simply designated types 1 through 62. This new system offers several advantages over traditional ITS1- and ITS2-based typing systems, including a simpler analysis and interpretation process, a higher discriminative power, and no limitation in assigning potential new genotypes. This new system is expected to facilitate the standardization of P. jirovecii genotyping and easy data exchanges across different laboratories.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Pneumocystis jiroveciizzm321990; genotypes; internal transcribed spacer; rRNA genes

Mesh:

Substances:

Year:  2019        PMID: 30918046      PMCID: PMC6535588          DOI: 10.1128/JCM.02012-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains.

Authors:  L Ma; J A Kovacs
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia.

Authors:  Anne Totet; Jean-Claude Pautard; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?

Authors:  Mark G J de Boer; Lesla E S Bruijnesteijn van Coppenraet; Andre Gaasbeek; Stefan P Berger; Luc B S Gelinck; Hans C van Houwelingen; Peterhans van den Broek; Ed J Kuijper; Frank P Kroon; Jan P Vandenbroucke
Journal:  Clin Infect Dis       Date:  2007-03-26       Impact factor: 9.079

4.  Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa.

Authors:  Frans J L Robberts; Lynne D Liebowitz; Lynda J Chalkley
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  The development of a typing method for an uncultivable microorganism: the example of Pneumocystis jirovecii.

Authors:  Philippe M Hauser
Journal:  Infect Genet Evol       Date:  2004-09       Impact factor: 3.342

6.  Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii.

Authors:  Liang Ma; Geetha Kutty; Qiuyao Jia; Hiromi Imamichi; Laurence Huang; Chiara Atzori; Pieter Beckers; Gena Groner; Charles B Beard; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2002-11-11       Impact factor: 5.226

7.  Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region.

Authors:  Gilles Nevez; Anne Totet; Vincent Jounieaux; Jean-Luc Schmit; Eduardo Dei-Cas; Christian Raccurt
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes.

Authors:  Sebastiaan J van Hal; Felix Gilgado; Tom Doyle; Joel Barratt; Damien Stark; Wieland Meyer; Jock Harkness
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

9.  Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients.

Authors:  S Gianella; L Haeberli; B Joos; B Ledergerber; R P Wüthrich; R Weber; H Kuster; P M Hauser; T Fehr; N J Mueller
Journal:  Transpl Infect Dis       Date:  2009-09-09       Impact factor: 2.228

10.  Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response.

Authors:  Chun Li An; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  2 in total

1.  Genetic Polymorphisms of Pneumocystis jirovecii in HIV-Positive and HIV-Negative Patients in Northern China.

Authors:  Ting Xue; Wei-Qin Du; Wen-Juan Dai; Yi-Shan Li; Shu-Feng Wang; Jun-Ling Wang; Xin-Ri Zhang
Journal:  Pol J Microbiol       Date:  2022-02-23

Review 2.  Consensus Multilocus Sequence Typing Scheme for Pneumocystis jirovecii.

Authors:  Lana Pasic; Lidia Goterris; Mercedes Guerrero-Murillo; Laszlo Irinyi; Alex Kan; Carolina A Ponce; Sergio L Vargas; M Teresa Martin-Gomez; Wieland Meyer
Journal:  J Fungi (Basel)       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.